I do not think we need record figures to keep the SP up. More...

I do not think we need record figures to keep the SP up. More important for the sales and market share to be trending up. A 29% total market share by volume up from 27% last quarter would be a good start.

Unless the record sales last quarter was a real 'one off' for whatever reason, there is a better chance than not of another consecutive record quarter anyway. The market would lap it up.

The aussie exchange rate for the previous reported quarter averaged around US0.97c whereas the quarter just gone it averaged about US0.92c so we should see a natural increase in sales income to ACL all things being equal.

I am looking for gross profit share to ACL of AUS$4.2m before COG improvement deduction.

I like the fact that ACL are assessing the potential monetisation of Fondaparinux with MULTIPLE parties. Not just Dr Reddys. Their words not mine.